Infliximab rescue of efalizumab withdrawal flare and psoriasis-precipitated depression.
Leona
L
Yip
Shannon
S
Harrison
Peter
P
Foley
D000368:Aged; D000911:Antibodies, Monoclonal / Q000009:adverse effects* / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D003863:Depression / Q000188:drug therapy / Q000209:etiology*; D003879:Dermatologic Agents / Q000627:therapeutic use*; D006801:Humans; D000069285:Infliximab; D008297:Male; D010349:Patient Compliance; D011565:Psoriasis / Q000150:complications* / Q000188:drug therapy; D013375:Substance Withdrawal Syndrome / Q000188:drug therapy*; D016896:Treatment Outcome
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D003879:Dermatologic Agents; D000069285:Infliximab; C472181:efalizumab